These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 22884162)

  • 1. Hepatic safety of caspofungin during treatment of invasive fungal diseases in elderly patients.
    Wang LL; Zhuge X; Xiao GH; Zhang Y
    Chin Med J (Engl); 2012 Jun; 125(12):2240. PubMed ID: 22884162
    [No Abstract]   [Full Text] [Related]  

  • 2. A retrospective analysis of the use of caspofungin in recipients of liver transplant with a modified high index of suspicion for fungal infection. A critical review of mortality, acute cellular rejection, infections, and changes in the liver function tests while on caspofungin.
    Doria C; Bodzin AS; Vaccino S; Daskalakis C; Krawitz S; Ramirez CB
    Clin Transplant; 2011; 25(4):569-75. PubMed ID: 20662881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Switching to anidulafungin from caspofungin in cancer patients in the setting of liver dysfunction is associated with improvement of liver function tests.
    Jung DS; Tverdek FP; Jiang Y; Kontoyiannis DP
    J Antimicrob Chemother; 2015 Nov; 70(11):3100-6. PubMed ID: 26311837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caspofungin.
    Parakh A; Dubey AP; Samanta D
    Indian Pediatr; 2008 Nov; 45(11):905-10. PubMed ID: 19029563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety experience with caspofungin in pediatric patients.
    Zaoutis T; Lehrnbecher T; Groll AH; Steinbach WJ; Jafri HS; Maertens J; Ngai AL; Chow JW; Taylor AF; Strohmaier KM; Bourque M; Bradshaw SK; Petrecz M; Kartsonis NA
    Pediatr Infect Dis J; 2009 Dec; 28(12):1132-5. PubMed ID: 19779392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of caspofungin or micafungin as empiric antifungal therapy in adult patients with persistent febrile neutropenia: a retrospective, observational, sequential cohort analysis.
    Kubiak DW; Bryar JM; McDonnell AM; Delgado-Flores JO; Mui E; Baden LR; Marty FM
    Clin Ther; 2010 Apr; 32(4):637-48. PubMed ID: 20435233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caspofungin as primary antifungal prophylaxis in stem cell transplant recipients.
    Chou LS; Lewis RE; Ippoliti C; Champlin RE; Kontoyiannis DP
    Pharmacotherapy; 2007 Dec; 27(12):1644-50. PubMed ID: 18041885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical utility of caspofungin eye drops in fungal keratitis.
    Neoh CF; Daniell M; Chen SC; Stewart K; Kong DC
    Int J Antimicrob Agents; 2014 Aug; 44(2):96-104. PubMed ID: 24933448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tolerance of caspofungin in intensive care unit: a prospective study].
    Constantin JM; Roszyk L; Guerin R; Bannier F; Chartier C; Perbet S; Futier E; Cayot-Constantin S; Sapin V; Bazin JE
    Ann Fr Anesth Reanim; 2008 Oct; 27(10):819-24. PubMed ID: 18835682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of caspofungin for the empiric management of fever in neutropenic children.
    Koo A; Sung L; Allen U; Naqvi A; Drynan-Arsenault J; Dekker A; Maloney AM; Dupuis LL
    Pediatr Infect Dis J; 2007 Sep; 26(9):854-6. PubMed ID: 17721388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Micafungin: new challenges, new possibilities in the treatment of invasive fungal infection].
    Pemán J; Torre-Cisneros J
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 2():1-2. PubMed ID: 21420569
    [No Abstract]   [Full Text] [Related]  

  • 12. Caspofungin for prophylaxis and treatment of fungal infections in adolescents and adults: a meta-analysis of randomized controlled trials.
    Yuan X; Wang R; Bai CQ; Song XJ; Liu YN
    Pharmazie; 2012 Apr; 67(4):267-73. PubMed ID: 22570929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accumulated safety data of micafungin in therapy and prophylaxis in fungal diseases.
    Cornely OA; Pappas PG; Young JA; Maddison P; Ullmann AJ
    Expert Opin Drug Saf; 2011 Mar; 10(2):171-83. PubMed ID: 21306282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Echinocandins: The Expanding Antifungal Armamentarium.
    Aguilar-Zapata D; Petraitiene R; Petraitis V
    Clin Infect Dis; 2015 Dec; 61 Suppl 6():S604-11. PubMed ID: 26567277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of fungal septicemia in a premature infant with caspofungin].
    Ding XC; Zhu XP; Xiao ZH
    Zhonghua Er Ke Za Zhi; 2008 Jun; 46(6):479-80; discussion 480. PubMed ID: 19099797
    [No Abstract]   [Full Text] [Related]  

  • 16. Caspofungin: new indication. Same indications in children as in adults.
    Prescrire Int; 2009 Aug; 18(102):155. PubMed ID: 19743569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Echinocandins: the newest class of antifungals.
    Sucher AJ; Chahine EB; Balcer HE
    Ann Pharmacother; 2009 Oct; 43(10):1647-57. PubMed ID: 19724014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experiences with the use of caspofungin in paediatric patients.
    Lehrnbecher T; Groll AH
    Mycoses; 2008; 51 Suppl 1():58-64. PubMed ID: 18471162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compassionate use study of caspofungin in children with proven or suspected invasive mycosis or persistent febrile neutropenia.
    Madero L; Sanchez de Toledo J; Castel V; Sevilla J; Gonzalez-Esteban J; Sanz-Rodriguez C
    J Chemother; 2009 Apr; 21(2):229-31. PubMed ID: 19423481
    [No Abstract]   [Full Text] [Related]  

  • 20. [Outcome analysis of caspofungin in combination with voriconazole for treatment of 12 hematologic malignancies cases with invasive fungal infection].
    Sun HL; Zhou X; Shen YF
    Zhonghua Xue Ye Xue Za Zhi; 2011 Aug; 32(8):558-9. PubMed ID: 22338183
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.